Marc WagnerPartner at Fox Rothschild LLPSpeaker
Profile
Marc devotes his practice to FDA and DEA compliance, regulatory enforcement and transactional matters in the healthcare and life sciences industries.
He advises pharmaceutical, biotechnology, medical device, dietary supplement, food and healthcare companies on the full spectrum of FDA regulatory issues throughout the product lifecycle, from product development and commercialization to inspections, enforcement and post-market compliance.
Marc represents drug manufacturers, outsourcing facilities, compounding pharmacies, wholesale distributors, third-party logistics providers, healthcare providers and other regulated entities in navigating complex federal and state regulatory requirements.
Agenda Sessions
Industry Outlook Session: The Regulatory, Legislative & Market Forces Reshaping Compounding
, 8:30amView Session
